CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Saint Louis, Missouri, United States and 73 other locations
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Saint Louis, Missouri, United States and 18 other locations
will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...
Phase 1
Saint Louis, Missouri, United States and 20 other locations
This is an open label, Phase 1b, multiple ascending dose, and dose-expansion study of IDP-023 administered in combination with interleukin-2 ...
Phase 1
Saint Louis, Missouri, United States and 3 other locations
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
Saint Louis, Missouri, United States and 76 other locations
This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis...
Phase 2
Saint Louis, Missouri, United States and 19 other locations
with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and \< 18 years over a dura...
Phase 3
Saint Louis, Missouri, United States and 121 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Saint Louis, Missouri, United States and 220 other locations
system (CNS) and blood biomarkers relevant in the relapsing forms of multiple sclerosis (RMS; to include relapsing-remitting MS...
Phase 4
Saint Louis, Missouri, United States and 4 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
Saint Louis, Missouri, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal